A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse

Launched by MEDICAL UNIVERSITY OF SOUTH CAROLINA · Nov 1, 2023

Keywords

ClinConnect Summary

This clinical trial is looking to improve how we help people who smoke and want to quit. The study will provide free treatments for 12 weeks, including nicotine patches, lozenges, and a medication called varenicline, as well as e-cigarettes for those who may benefit from them. Participants will receive a mix of these options based on how they respond to each treatment. The goal is to see which approach works best for helping smokers stay quit.

To join the study, you need to be a smoker who genuinely wants to quit. The trial is open to anyone aged 18 and older, regardless of gender. All visits and assessments will be done online, making it easy to participate from home. After the initial 12 weeks, the study team will follow up with you through a phone call to complete a survey about your experience six months later. This study is a great opportunity to get support for quitting smoking at no cost while helping improve treatment options for future smokers.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Smokers who want to quit
• Exclusion Criteria:
• • Non-smokers